Latest News
20 March 2023
Non-canonical proteins as candidate targets for cancer immunotherapy
Non-canonical proteins are unconventional protein products that are not part of the known protein-coding genome repertoire. They arise from unexpected...
15 March 2023
Cancer-related secondary/incidental exome results in patients with rare, non-oncological malignancies: the clinical impact and psychological implications
Recently published in the Journal of Medical Genetics* results of a case-control study spearheaded by VHIO’s Judith Balmaña show that...
13 March 2023
Efficacy and safety of next-generation FGFR inhibitor futibatinib in patients with metastatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is a rare cancer with a poor prognosis. Surgery is the main curative option but up to...
10 March 2023
ESMO Daily Reporter On target column: VHIO’s Elena Garralda on cellular immunotherapy against solid tumors
Now published by the ESMO Daily Reporter (formerly by the ESMO Perspectives online magazine), the latest edition of On Target – Gathering...
Research Programs
PRECLINICAL & TRANSLATIONAL RESEARCH
Cellular Plasticity and Cancer Group
Our group focuses on the interplay between cellular plasticity, stem cells and cancer. Cellular plasticity is recognized today as a critical feature of cancer cells that enables them to transit between different cellular states, including reversible transitions.
PRECLINICAL & TRANSLATIONAL RESEARCH
Growth Factors Group
We focus our research on mechanisms of resistance to targeted therapies and most importantly, how to overcome it by showing that breast cancers resistant to T-DM1, an antibody-drug conjugate ADC)- can be efficiently treated with the second generation ADC SYD985 (Nadal-Serrano et al.).
CORE TECHNOLOGIES
Cancer Genomics Group
VHIO’s Cancer Genomics Group serves as a Core Technology laboratory. We are also dedicated to translational research as well as the development of novel genomic tests.
PRINCIPAL RESEARCHERS
Events
Friday 24 March 23 - 12:00 PM
scientific-seminars Seminars
Jakob Kather | Artificial intelligence-based biomarkers in precision oncology
Friday 24 March 23 - 02:50 PM
Seminars
4ª SESIÓN DE ACTUALIZACIÓN EN TERAPIAS DIRIGIDAS EN PACIENTES ALK+ Y EGFR
Thursday 30 March 23 - 11:00 AM
Patients
Mindfulness workshop. Learning to live and enjoy the present
Thursday 20 April 23 - 11:00 AM
Patients
Practical physical exercise workshop. How can we reconnect with our body through the practice of physical exercise?
